/

|

Dive Brief:
Johnson & Johnson is investing $2 billion in a biologics manufacturing facility in Wilson, North Carolina, the drugmaker announced Tuesday.

The plant will support Johnson & Johnson’s existing drug portfolio, as well as support the company’s plan to launch 70 therapy and product expansions by 2030. Drug production will cover areas such as oncology, immunology and neuroscience.

Construction is slated to begin in the first half of next year. When fully operational, the facility will create 420 full-time jobs.